A. O. Smith (NYSE:AOS) Given Hold (C) Rating at Weiss Ratings
Weiss Ratings reaffirmed their hold (c) rating on shares of A. O. Smith (NYSE:AOS – Free Report) in a research note published on Saturday morning,Weiss Ratings reports. A number of other equities analysts also recently commented on the company. Citigroup lowered their price objective on A. O. Smith from $69.00 to $65.00 and set a […]
2seventy bio’s (TSVT) Sell (D-) Rating Reiterated at Weiss Ratings
Weiss Ratings restated their sell (d-) rating on shares of 2seventy bio (NASDAQ:TSVT – Free Report) in a research report released on Saturday,Weiss Ratings reports. Several other analysts also recently weighed in on TSVT. Morgan Stanley lowered their price target on shares of 2seventy bio from $6.00 to $5.00 and set an “equal weight” rating […]
4D Molecular Therapeutics’ (FDMT) Sell (E+) Rating Reiterated at Weiss Ratings
Weiss Ratings reissued their sell (e+) rating on shares of 4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) in a research note released on Saturday morning,Weiss Ratings reports. A number of other analysts have also recently commented on the stock. Bank of America cut their price target on shares of 4D Molecular Therapeutics from $42.00 to […]
A10 Networks (NYSE:ATEN) Cut to “Hold (C)” at Weiss Ratings
Weiss Ratings cut shares of A10 Networks (NYSE:ATEN – Free Report) from a buy (b-) rating to a hold (c) rating in a research note published on Saturday morning,Weiss Ratings reports. Other research analysts have also recently issued research reports about the company. BWS Financial reaffirmed a “buy” rating and set a $24.00 target price […]
last updated on 13 May 06:26